Tuomas Kiviniemi
MD, PhD, FESC
tuoski@utu.fi |
Cardiology; Clinical trials; Atrial fibrillation; Coronary artery disease; Percutaneous coronary intervention; Wearables; Anticoagulation; Bleeding; Translational research
Professor of cardiology, PI in CAREFIB and LAA-CLOSURE
Tuomas Kiviniemi, MD, PhD, FESC, is Professor of Cardiology at the University of Turku and Chief Physician at the Heart Center, Turku University Hospital. His clinical and academic work focuses on interventional cardiology, atrial fibrillation, and cardiovascular risk in patients undergoing cardiac procedures. He also serves as President of the Finnish Cardiac Society for the 2024–2026 term, contributing nationally to cardiovascular care development and professional education.
Professor Kiviniemi completed his medical and doctoral degrees at the University of Turku and later broadened his research expertise during a research fellowship at Brigham and Women’s Hospital, Harvard Medical School. His research integrates clinical trials, biomarker studies, translational science, and outcome research in percutaneous and surgical cardiac interventions. He leads the multidisciplinary CAREFIB Consortium, which encompasses several major investigator-initiated studies, including CAREBANK, CAREiCON and the LAA-CLOSURE randomized trial program investigating stroke prevention strategies in atrial fibrillation.
His scientific output includes peer-reviewed publications, book chapters, trial leadership roles, and long-term collaborations with computational medicine, imaging, and device-innovation groups.
In addition to his academic duties, Professor Kiviniemi is a frequently invited expert in the European Society of Cardiology community, contributing as an abstract reviewer, session chair, and presenter in acute coronary syndromes and interventional cardiology themes.
At the national level, he has served as a long-standing member and chair within the Finnish Cardiac Society, holding multiple leadership and editorial roles. As President of the Society 2024-2026, he advanced cardiovascular education, guidelines, and professional collaboration across Finland.
Professor Kiviniemi’s current research interests span atrial fibrillation detection technologies, outcomes after cardiac surgery, advanced imaging, and digital health solutions. His work continues to bridge clinical cardiology with engineering, data science, and translational discovery, supporting the University of Turku’s strategic strengths in cardiovascular medicine.
At the University of Turku, Professor Kiviniemi is actively involved in supervising doctoral trainees in cardiology, and he has mentored more than ten completed PhD theses. His teaching activities also include specialist training and contributions to national cardiology textbooks.
- CHADS2 and CHA2DS2-VASc scores as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention (2013)
- European Heart Journal
- Erratum to: Neointimal coverage and vasodilator response to titanium-nitride-oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome – insights from the BASE-ACS trial (2013)
- International Journal of Cardiovascular Imaging
- Performance of bleeding risk-prediction scores in patients with atrial fibrillation undergoing percutaneous coronary intervention (2013)
- European Heart Journal
- Renal impairment and prognosis of patients with AF undergoing PCI - The AFCAS trial (2013)
- European Heart Journal
- Thrombocytopenia in Patients With Atrial Fibrillation on Oral Anticoagulation Undergoing Percutaneous Coronary Intervention (2013)
- American Journal of Cardiology
- Vascular Healing Early After Titanium-Nitride-Oxide-Coated Stent Implantation Assessed by Optical Coherence Tomography (2013)
- Journal of Invasive Cardiology
- Comparison of additional versus no additional heparin during therapeutic oral anticoagulation in patients undergoing percutaneous coronary intervention (2012)
- American Journal of Cardiology
- Early Vascular Healing After Endothelial Progenitor Cell Capturing Stent Implantation (2012)
- Journal of Invasive Cardiology
- Impaired ATP-Induced Coronary Blood Flow and Diminished Aortic NTPDase Activity Precede Lesion Formation in Apolipoprotein E-Deficient Mice (2012)
- American Journal of Pathology
- Pravastatin-induced improvement in coronary reactivity and circulating ATP and ADP levels in young adults with type 1 diabetes (2012)
- Frontiers in Physiology
- Sepelvaltimoahtauman arviointi kajoavilla menetelmillä (2012)
- Lääkärilehti
- Cold Pressor Test Safety-The Incidence of Vasovagal Reactions (2011)
- American Journal of Cardiology
- Cardiopulmonary involvement in Fabry's disease (2010)
- Acta Cardiologica
- Decreased endothelin-1 levels after acute consumption of red wine and de-alcoholized red wine (2010)
- Atherosclerosis
- Cardiac magnetic resonance imaging in valvular heart disease (2009)
- Clinical Physiology and Functional Imaging
- Echocardiography in Fabry disease: diagnostic value of endocardial border binary appearance (2009)
- Clinical Physiology and Functional Imaging
- High dose of red wine elicits enhanced inhibition of fibrinolysis (2009)
- European Journal of Cardiovascular Prevention and Rehabilitation
- Assessment of coronary blood flow and the reactivity of the microcirculation non-invasively with transthoracic echocardiography (2008)
- Clinical Physiology and Functional Imaging
- Effects of cognac on coronary flow reserve and plasma antioxidant status in healthy young men (2008)
- Cardiovascular Ultrasound
- A moderate dose of red wine, but not de-alcoholized red wine increases coronary flow reserve (2007)
- Atherosclerosis



